IGC Pharma
5 hedge funds and large institutions have $36K invested in IGC Pharma in 2014 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, reducing their positions, and 3 closing their positions.
17% less funds holding
Funds holding: 6 → 5 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
92% less capital invested
Capital invested by funds: $462K → $36K (-$426K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VKH
Virtu KCG Holdings
New York
|
+$19.5K |
| 2 |
Creative Planning
Overland Park,
Kansas
|
+$8.03K |
| 3 |
U
UBS
Zurich,
Switzerland
|
+$2.06K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$417K |
| 2 |
Goldman Sachs
New York
|
-$15K |
| 3 |
BRWA
B. Riley Wealth Advisors
Boca Raton,
Florida
|
-$320 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Creative Planning
Overland Park,
Kansas
| $20K | +$8.03K | +8,250 | +41% |
|
|
VKH
2
Virtu KCG Holdings
New York
| $14K | +$19.5K | +20,040 | New |
|
|
VIA
3
Vantage Investment Advisors
State College,
Pennsylvania
| $1K | – | – | – |
|
|
U
4
UBS
Zurich,
Switzerland
| $1K | +$2.06K | +2,112 | New |
|
|
5
Wells Fargo
San Francisco,
California
| – | -$417K | -293,442 | Closed |
|
|
6
Goldman Sachs
New York
| – | -$15K | -10,437 | Closed |
|
|
BRWA
7
B. Riley Wealth Advisors
Boca Raton,
Florida
| – | -$320 | -225 | Closed |
|
IGC Hedge Fund Activity: Q3 2014 in Review
5 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in IGC Pharma (IGC) for Q3 2014, worth a combined $36K — down 92% from $462K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of IGC and 2 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.
The largest buyer was Virtu KCG Holdings, opening a new position worth an estimated $19.5K. The largest seller was Wells Fargo, exiting entirely with an estimated $417K sold.
- 5 institutional investors held IGC Pharma (IGC) as of Q3 2014, down from 6 in Q2 2014.
- Funds reported $36K of IGC Pharma stock for Q3 2014, down 92% quarter-over-quarter.
- 2 funds opened new IGC Pharma positions in Q3 2014 and 3 closed out, a net change of -1 holder.
- The largest IGC Pharma buyer in Q3 2014 was Virtu KCG Holdings, an estimated $19.5K added.
- The largest IGC Pharma seller in Q3 2014 was Wells Fargo, an estimated $417K sold.
Based on aggregated 13F filings for Q3 2014.